Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

METRA RAISES $6 MILLION IN FINANCING

Feb. 6, 1992

ECOSCIENCE RAISES $28.6 MILLION IN IPO

Feb. 6, 1992

VESTAR OFFERING RAISES $50 MILLION

Feb. 6, 1992

ENCOURAGING DATA FROM IMMUNEX TRIALS

Feb. 6, 1992

ANALYSTS QUESTION U.S. BIO STOCK TRADING

Feb. 5, 1992

UNIVAX IPO RAKES IN $48 MILLION

Feb. 5, 1992

CENTOCOR ACQUIRES DIAGNOSTICS COMPANY

Feb. 5, 1992

ORGANOGENESIS TO EXPAND TRIALS

Feb. 5, 1992

ADVANCED POLYMER NETS $8.74 MILLION

Feb. 5, 1992

U.S. BIO PLANS FEBRUARY MEETING WITH FDA

Feb. 5, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...